Tenaya Therapeutics Inc (TNYA)
4.25
-0.41
(-8.80%)
USD |
NASDAQ |
May 20, 16:00
4.255
0.00 (0.00%)
Pre-Market: 20:00
Tenaya Therapeutics Total Assets (Quarterly): 184.90M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 184.90M |
December 31, 2023 | 170.52M |
September 30, 2023 | 193.40M |
June 30, 2023 | 220.75M |
March 31, 2023 | 245.34M |
December 31, 2022 | 278.94M |
September 30, 2022 | 226.31M |
Date | Value |
---|---|
June 30, 2022 | 255.93M |
March 31, 2022 | 281.50M |
December 31, 2021 | 314.19M |
September 30, 2021 | 331.79M |
June 30, 2021 | 156.90M |
March 31, 2021 | 159.76M |
December 31, 2020 | 148.16M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
148.16M
Minimum
Dec 2020
331.79M
Maximum
Sep 2021
226.31M
Average
223.53M
Median
Total Assets (Quarterly) Benchmarks
Biomarin Pharmaceutical Inc | 6.873B |
Corvus Pharmaceuticals Inc | 40.08M |
Solid Biosciences Inc | 248.69M |
Dyne Therapeutics Inc | 522.28M |
Sana Biotechnology Inc | 681.38M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 26.72M |
Shareholders Equity (Quarterly) | 158.18M |